Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rhox2a Inhibitors

Rhox2a inhibitors are a class of chemical compounds that specifically target and inhibit the function of Rhox2a, a transcription factor from the Rhox (Reproductive Homeobox) gene family. Rhox2a plays a critical role in regulating the transcription of genes involved in reproductive and developmental processes. Like other members of the homeobox family, Rhox2a contains a conserved DNA-binding domain that allows it to interact with specific DNA sequences, controlling the expression of genes related to cell growth, differentiation, and tissue development, particularly within reproductive tissues. Inhibitors of Rhox2a typically function by binding to essential regions of the protein, such as its DNA-binding domain, thereby preventing Rhox2a from attaching to target gene promoters and interfering with its transcriptional activity.

The inhibition of Rhox2a leads to significant changes in the gene expression programs it regulates, affecting key biological processes that rely on its control. By blocking Rhox2a, these inhibitors disrupt the normal transcriptional networks that orchestrate reproductive tissue development and cellular differentiation. Researchers employ Rhox2a inhibitors as valuable tools to study the specific roles that Rhox2a plays in gene regulatory networks, providing insights into how this transcription factor influences developmental and reproductive processes at the molecular level. Additionally, Rhox2a inhibitors help scientists explore the functional relationships within the Rhox family, allowing them to investigate how different Rhox proteins contribute to various biological pathways. Furthermore, these inhibitors offer a window into the evolutionary conservation and specialization of homeobox genes across different species, providing a deeper understanding of how transcription factors like Rhox2a have adapted to regulate gene expression in the context of reproduction and development. Through the study of Rhox2a inhibitors, researchers can enhance their knowledge of the molecular mechanisms that govern gene regulation during key biological processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound can be incorporated into DNA and RNA. It may inhibit DNA methylation, which could alter the expression of genes like Rhox2a by affecting epigenetic regulation.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic Acid is also a histone deacetylase inhibitor. It could disrupt histone modification and the resulting chromatin structure, potentially reducing Rhox2a expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

As a histone deacetylase inhibitor, Sodium Butyrate can affect chromatin remodeling, which might result in downregulation of genes like Rhox2a.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid affects gene expression through its role as a ligand for nuclear receptors. It could alter the transcriptional regulation of Rhox2a.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Vitamin D3, through its active metabolite, can modulate transcription factor binding to DNA, potentially reducing the expression of Rhox2a.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds to DNA and can inhibit transcription factor binding, which may decrease Rhox2a expression by preventing transcriptional activation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR signaling, which is involved in protein synthesis and cell growth. This inhibition might indirectly downregulate Rhox2a expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which could lead to reduced activity in signaling pathways that regulate gene expression, including Rhox2a.

LGK 974

1243244-14-5sc-489380
sc-489380A
5 mg
50 mg
$359.00
$1295.00
2
(0)

Wnt-C59 is an inhibitor of Wnt/β-catenin pathway. It may alter the transcriptional program of cells, potentially affecting the expression of Rhox2a.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

DAPT is a gamma-secretase inhibitor. It may impact Notch signaling, leading to changes in gene expression patterns, including the downregulation of Rhox2a.